Kondro, Wayne
December 2008
CMAJ: Canadian Medical Association Journal;12/2/2008, Vol. 179 Issue 12, p1262
Academic Journal
The article offers medical news briefs. Additional medical practices were listed to Accreditation Canada's required organization practices including hand-hygiene compliance, heparin safety and narcotic safety. According to the U.S. Government Accountability Office, Food and Drug Administration's monitoring of foreign drug manufacturing plants is lax and inadequate. China introduced a draft for its health-reform plan which proposes equitable and universal access to basic health services by 2010.


Related Articles

  • Reformers seek greater transparency in drug prices, marketing, and research. Wechsler, Jill // Formulary;Mar2009, Vol. 44 Issue 3, p86 

    The article focuses on the prominent theme in health-reform. The U.S. Food and Drug Administration (FDA) had developed an online system for posting quarterly lists of drugs with potential signals of serious risks. Furthermore, FDA will issue Early Communication notices and had launched the drug...

  • Sentinel to Transform Drug Development and Oversight. Wechsler, Jill // Pharmaceutical Technology;Aug2008, Vol. 32 Issue 8, p30 

    The article reports on the launch of the Sentinel Initiative by the U.S. Food and Drug Administration (FDA). It notes on its goal to expand and improve the medical-product risk identification and evaluation as well as to implement a provision in the FDA Amendments Act of 2007 (FDAAA) requiring...

  • McClellan Offers Advice on Health Reform, Drug Safety. J. W. // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p22 

    The article reports that the former U.S. Food and Drug Administration commissioner and Medicare chair, Mark McClellan will lead the Engelberg Center for Health Care Reform at the Brookings Institution. The report said that with $20 million in funding from Alfred Engelberg and Leonard Schaeffer,...

  • Budget crunch, political battles shape 2012 policy agenda. Wechsler, Jill // Formulary;Jan2012, Vol. 47 Issue 1, p41 

    The article presents an overview of the impact that election year politics and health care reform will have on legislative and policy developments affecting drug development, production, and reimbursement in 2012. A discussion of the 2012 plans that the U.S. Supreme Court has to render a...

  • Switch Hitters. Veiders, Christina // SN: Supermarket News;6/22/2009, Vol. 57 Issue 25, p14 

    The article reports on the switch of several prescription drugs to over-the-counter drugs in the U.S. It says that the switch was made because of recessionary pressures and demand for health care reform. According to Laura Mahecha, industry manager of Kline & Co., new OTC drugs coming to the...

  • The Slide Down The Slippery Slope Begins. Arvak, Jason // Moderate Voice;4/20/2010, p15 

    The article focuses on the impact of government's administration on the health care of Americans in the U.S. It accounts the possible changes on the passage of the health care reform, initially seeing the regulation of salt consumption in processed foods by the U.S. Food and Drug Administration...

  • FDA unveils new safety monitoring communication system.  // Hem/Onc Today;7/10/2010, Vol. 10 Issue 13, p34 

    The article reports on a drug and biologic safety monitoring communication system launched by the U.S. Food and Drug Administration (FDA).

  • NEWS NOW.  // American Family Physician;12/1/2009, Vol. 80 Issue 11, p1199 

    This section offers news briefs on medical policy and health issues in the U.S. as of December 2009. Delegates of the American Medical Association have adopted a measure that supports health care reform. The Food and Drug Administration (FDA) is working to revise the prescribing information for...

  • Regulatory Initiatives for Dietary Supplements.  // FDA Consumer;Jan/Feb2005, Vol. 39 Issue 1, p27 

    Deals with the three major regulatory initiatives announced by the U.S. Food & Drug Administration (FDA) designed to further implement the Dietary Supplement Health and Education Act of 1994. List of federal agencies and organizations that the FDA will collaborate with to improve the factual...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics